Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIV protease, also known as HIV-1 protease or PR, is a retroviral aspartyl protease enzyme that plays an essential role in the life cycle of the human immunodeficiency virus (HIV), which causes AIDS. It is responsible for cleaving newly synthesized polyproteins—specifically Gag and Gag-Pol—at multiple sites to generate mature protein components necessary for assembling infectious viral particles. The enzyme’s activity is crucial for viral maturation; without it, HIV particles remain non-infectious. In addition to its well-characterized role in virion maturation, recent research suggests that HIV protease can also cleave certain host cell proteins involved in translation regulation, apoptosis, and antiviral responses. This may help modulate host cell function and promote immune evasion during infection.
Competitive inhibition of HIV protease, preventing proper processing of viral proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type I Protease.